Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-03

Clinical Trial Update: Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the effects of Xenin-25 in adults with and without Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenin-25

Snippet

Sponsor: Washington University School of Medicine | Conditions: Diabetes | Phase 1 | Status: COMPLETED